Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Frontiers in Pharmacology|May 13, 2022
The Practical Problem With Carbapenem Testing and Reporting Accurate Bacterial SusceptibilitiesMark Redell, Glenn S TillotsonExpert Review of Clinical Pharmacology|January 14, 2014
Antibiotic resistance: the challenge from an industry perspectiveGlenn S TillotsonExpert Review of Anti-Infective Therapy|July 30, 2008
Role of gemifloxacin in community-acquired pneumoniaGlenn S TillotsonIdrugs : the Investigational Drugs Journal|May 10, 2008
Antibiotic development: a victim of market forces?Glenn S TillotsonInfectious Diseases|October 25, 2016
Trojan Horse Antibiotics-A Novel Way to Circumvent Gram-Negative Bacterial Resistance?Glenn S TillotsonF1000 Medicine Reports|June 10, 2011
Clostridium difficile--a moving targetGlenn S Tillotson, Joni TillotsonClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2015
The Regulatory Pathway for Antifungal Drugs: A US PerspectiveJoni Tillotson, Glenn S TillotsonF1000Prime Reports|January 2, 2014
New and alternative approaches to tackling antibiotic resistanceGlenn S Tillotson, Nicolette TheriaultChest|August 16, 2005
The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumoniaKarl Weiss, Glenn S TillotsonThe Journal of Antimicrobial Chemotherapy|June 28, 2007
Meeting report: Fourth Forum on Respiratory Tract Infections, Sitges, Spain, 8 11 February 2007Glenn S Tillotson, Peter BallPageof 5